[Treatment of urinary tract infections by dibekacin].
In this cooperative trial, 181 patients with various urinary tract infections were treated by dibekacin, a new hemi-synthetic aminoglycoside. Clinical and bacteriological results confirm the efficacy of dibekacin in this indication. Local and systemic tolerance, and thus renal and cochleo-vestibular, were very satisfactory.
D003982:Dibekacin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D003982:Dibekacin; D007612:Kanamycin
Traitement des infections urinaries par la dibékacine.